Filter by tags: Research reactor Europe Clear all tag filters
3 news articles found
Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.
Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.
According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.
- Source: Nucnet
- Date: Friday, 14 April 2023
- Original article: nucnet.org/news/sector-aims-to-tackle-isotope-supply-problems-as-excitement-grows-over-targeted-therapies-4-4-2023
France's Framatome and the Technical University of Munich (TUM) in Germany have started commercial development of nuclear research reactor fuels based on uranium-molybdenum fuel (U-Mo) alloys. The fuel can be used instead of highly enriched uranium (HEU), which is seen as a potential nuclear proliferation risk.
- Source: World Nuclear News
- Date: Wednesday, 06 May 2020
- Original article: world-nuclear-news.org/Articles/Framatome-TUM-to-develop-new-research-reactor-fuel
Canadian Nuclear Laboratories (CNL) announced on 2 April that isotope production reactor the National Research Universal (NRU) at the Chalk River site had been permanently shut down. It will now be placed into a "state of storage" prior to decommissioning. The reactor, which produced about 40% of world supply of molybdenum-99 (Mo-99), ceased production in October 2016, since when it has remained on standby "in case of a significant shortage which could not be mitigated by other means". Research reactors in Australia, Europe, Russia and South Africa have since met demand.
- Source: NEI Magazine
- Date: Friday, 06 April 2018
- Original article: neimagazine.com/news/newscanada-permanently-closes-nru-research-reactor-6107149